Overview: This page contains the latest trade data of Vaccines, human use. In 2018, Vaccines, human use were the world's 82nd most traded product, with a total trade of $30.5B. Between 2017 and 2018 the exports of Vaccines, human use grew by 24.9%, from $24.4B to $30.5B. Trade in Vaccines, human use represent 0.17% of total world trade.
Exports: In 2018 the top exporters of Vaccines, human use were Ireland ($8.15B), Belgium-Luxembourg ($6.37B), France ($3.81B), United Kingdom ($3.47B), and United States ($2.52B).
Imports: In 2018 the top importers of Vaccines, human use were United States ($7.54B), Belgium-Luxembourg ($6.45B), United Kingdom ($2.33B), Germany ($1.59B), and France ($988M).
Tariffs: In 2018 the average tariff for Vaccines, human use was 0.81%, been the 6386 lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Vaccines, human use are India (8.18%), Aruba (6%), Pakistan (5.57%), Mongolia (4.98%), and Chad (4.9%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Algeria (0%), Egypt (0%), and Ethiopia (0%).
Ranking: Vaccines, human use ranks 1333rd in the Product Complexity Index (PCI).